Spinocerebellar Ataxia
What's New
Last Posted: Jun 30, 2023
- Genetic screening for Huntington disease phenocopies in Sweden: A tertiary center case series focused on short tandem repeat (STR) disorders.
Martin Paucar et al. J Neurol Sci 2023 451120707 - The potential value of disease-modifying therapy in patients with spinocerebellar ataxia type 1: an early health economic modeling study.
Teije van Prooije et al. J Neurol - Screening for the FMR1 premutation in Greek patients with late-onset movement disorders.
Kartanou Chrisoula et al. Parkinsonism & related disorders 2022 107105253 - Genome-wide sequencing as a first-tier screening test for short tandem repeat expansions.
Rajan-Babu Indhu-Shree et al. Genome medicine 2021 13(1) 126 - Repeats expansions in ATXN2, NOP56, NIPA1 and ATXN1 are not associated with ALS in Africans.
Nel Melissa et al. IBRO neuroscience reports 2021 10130-135 - Prediction of the Age at Onset of Spinocerebellar Ataxia Type 3 with Machine Learning.
Peng Linliu et al. Movement disorders : official journal of the Movement Disorder Society 2020 Sep - Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study.
Jacobi Heike et al. The Lancet. Neurology 2020 Sep 19(9) 738-747 - Evidence and practices of the use of next generation sequencing in patients with undiagnosed autosomal dominant cerebellar ataxias: a review.
Novis Luiz Eduardo et al. Arquivos de neuro-psiquiatria 2020 Jul - Molecular Diagnosis of Hereditary Neuropathies by Whole Exome Sequencing and Expanding the Phenotype Spectrum.
Taghizadeh Sara et al. Archives of Iranian medicine 2020 Jul 23(7) 426-433 - Hereditary Ataxias in Cuba: Results and Impact of a Comprehensive, Multidisciplinary Project.
Rodríguez-Labrada Roberto et al. MEDICC review 2019 Oct 21(4) 39-45
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: